Cepheid Gets FDA Approval for Xpert CT/NG
Delivering Rapid Detection and Differentiation of Chlamydia and N. gonorrhoeae
Read MorePosted by Judy O'Rourke | Dec 28, 2012 | Infectious Diseases, Sexually Transmitted Diseases |
Delivering Rapid Detection and Differentiation of Chlamydia and N. gonorrhoeae
Read MorePosted by Judy O'Rourke | Dec 24, 2012 | Cancer, Miscellaneous |
CLP recently spoke with David Hout, PhD, VP of R&D, Insight Genetics, about continuing work on the Insight ALK Screen, Insight ALK Resistance, and other biomarker-specific diagnostic tools to advance cancer care.
Read MorePosted by Judy O'Rourke | Dec 21, 2012 | Cancer, Miscellaneous |
A 5-year, $1.3 million grant from the NIH funds an innovative program to help pathologists understand genomics information and serve as primary consultants for physicians and patients in interpreting and acting on this data.
Read MorePosted by Judy O'Rourke | Dec 11, 2012 | Clinical Chemistry, Clinical Chemistry Analyzers, Clinical Chemistry Test Kits, Electrolytes, Miscellaneous, POC Instruments, POC Rapid Assays, POC Reagents & Test Kits |
The POC test market expands with demands related to outcomes, efficiency, data management, integration, and regulatory pressures.
Read MorePosted by Judy O'Rourke | Dec 7, 2012 | Information Technology, Lab Equipment |
Familiarize yourself with new products on the market.
Read More